Stone House Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.06K | Sell |
1,000
-200
| -17% | -$1.01K | ﹤0.01% | 323 |
|
|
2025
Q1 | $6.35K | Buy |
+1,200
| New | +$6.35K | ﹤0.01% | 292 |
|
|
2024
Q4 | – | Sell |
-1,000
| Closed | -$6.59K | – | 290 |
|
|
2024
Q3 | $6.59K | Hold |
1,000
| – | – | ﹤0.01% | 251 |
|
|
2024
Q2 | $7.5K | Buy |
1,000
+905
| +953% | +$6.79K | ﹤0.01% | 246 |
|
|
2024
Q1 | $947 | Buy |
+95
| New | +$947 | ﹤0.01% | 386 |
|